BioStem Technologies, Inc. (OTCMKTS:BSEM – Get Free Report)’s share price dropped 0.6% on Wednesday . The company traded as low as $4.77 and last traded at $4.80. Approximately 32,700 shares changed hands during trading, a decline of 55% from the average daily volume of 72,406 shares. The stock had previously closed at $4.83.
BioStem Technologies Stock Down 0.6%
The business has a 50-day moving average price of $6.82 and a 200-day moving average price of $10.18. The firm has a market capitalization of $80.49 million, a price-to-earnings ratio of 4.21 and a beta of -0.44.
BioStem Technologies Company Profile
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
See Also
- Five stocks we like better than BioStem Technologies
- Stock Sentiment Analysis: How it Works
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- How to Choose Top Rated Stocks
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- 5 discounted opportunities for dividend growth investors
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
